524606 Stock Overview
Beryl Drugs Limited manufactures and markets branded and generic pharmaceutical formulations in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Beryl Drugs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹34.70 |
| 52 Week High | ₹44.98 |
| 52 Week Low | ₹12.61 |
| Beta | 0.75 |
| 1 Month Change | 14.37% |
| 3 Month Change | 43.09% |
| 1 Year Change | 155.15% |
| 3 Year Change | 467.92% |
| 5 Year Change | 385.31% |
| Change since IPO | 4,719.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524606 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.1% | -0.5% | 1.4% |
| 1Y | 155.1% | 55.3% | 46.1% |
Return vs Industry: 524606 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 524606 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 524606 volatility | |
|---|---|
| 524606 Average Weekly Movement | 12.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524606's share price has been volatile over the past 3 months.
Volatility Over Time: 524606's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Sanjay Sethi | www.beryldrugs.com |
Beryl Drugs Limited manufactures and markets branded and generic pharmaceutical formulations in India and internationally. It offers bulk drugs, intermediates, surgical, drug formulations, biologicals, and Ayush and herbal products. The company provides I.V. fluids and small volume injectables, as well as veterinary products.
Beryl Drugs Limited Fundamentals Summary
| 524606 fundamental statistics | |
|---|---|
| Market cap | ₹176.14m |
| Earnings (TTM) | ₹11.79m |
| Revenue (TTM) | ₹298.64m |
14.9x
P/E Ratio0.6x
P/S RatioIs 524606 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524606 income statement (TTM) | |
|---|---|
| Revenue | ₹298.64m |
| Cost of Revenue | ₹136.61m |
| Gross Profit | ₹162.04m |
| Other Expenses | ₹150.25m |
| Earnings | ₹11.79m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.32 |
| Gross Margin | 54.26% |
| Net Profit Margin | 3.95% |
| Debt/Equity Ratio | 55.0% |
How did 524606 perform over the long term?
See historical performance and comparison